CARDIOVASCULAR
hamburger

Reimbursement & Coding

Abbott offers coding and reimbursement resources for Abbott cardiac rhythm management (CRM) devices, including resources relevant to the Durata™ defibrillation lead.

Coding Guides & Resources

Cardiac Rhythm Management Coding Guide

Find Medicare coding and national payment rates for cardiac rhythm management.

Cardiac Device Monitoring: CPT Codes and Common Questions

Find a summary of Medicare coding and answers to Frequently Asked Questions for device monitoring for Pacemakers, Implantable Cardioverter Defibrillators (ICD), Cardiac Resynchronization Therapy (CRT) and Insertable/Implantable Cardiac Monitors (ICM).

HCPCS Device Category C-codes Guide

Current reimbursement Healthcare Procedural Coding System (HCPCS) Device Category C-codes.

Centers for Medicare and Medicaid (CMS)

Implantable Cardioverter Defibrillators NCD

Developed through an evidence-based process, this National Coverage Determination guide provides details on required medical criteria that must be met for coverage of Medicare beneficiaries.

Implantable Cardioverter Defibrillator National Coverage Determination FAQs

Coverage considerations and Frequently Asked Questions regarding ICDs.

Webinars

2019/2020 Reimbursement Update: Cardiac Rhythm Management

This one-hour webcast addresses coding, payment and national coverage indications for Pacemakers, Implantable Cardioverter Defibrillators (ICDs), and Cardiac Resynchronization Therapy (CRT-P/CRT-D). It provides an overview of payment under Medicare’s FY 2020 Inpatient Prospective Payment System (IPPS) and Medicare’s FY 2019 Physician Fee Schedule (PFS), Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) payment system. The program also includes common patient scenarios and how to appropriately report to Medicare.

Health Economic Summit Episode 1 - Cardiac Resynchronization Therapy

This program is a one-hour webcast facilitated by cardiologist Dr. John Rogers. Economic and product specific topics related to CRT will be addressed including patient outcomes, Medicare reimbursement, and the economics of heart failure.

HE&R Disclaimer

This document and the information contained herein is for general information purposes only and is not intended, and does not constitute, legal, reimbursement, business, clinical, or other advice. Furthermore, it is not intended to and does not constitute a representation or guarantee of reimbursement, payment, or charge, or that reimbursement or other payment will be received. It is not intended to increase or maximize payment by any payer. Similarly, nothing in this document should be viewed as instructions for selecting any particular code, and Abbott does not advocate or warrant the appropriateness of the use of any particular code. The ultimate responsibility for coding and obtaining payment/reimbursement remains with the customer. This includes the responsibility for accuracy and veracity of all coding and claims submitted to third-party payers. In addition, the customer should note that laws, regulations, and coverage policies are complex and are updated frequently, and, therefore, the customer should check with its local carriers or intermediaries often and should consult with legal counsel or a financial, coding, or reimbursement specialist for any questions related to coding, billing, reimbursement or any related issues. This update reproduces information for reference purposes only. It is not provided or authorized for marketing use.

MAT-2011147 v1.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2019 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.